Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

December 30, 2024

Conditions
Bipolar Disorder
Interventions
OTHER

Probiotic Group

The 84 participants will participate in a randomized, double-blind, placebo-controlled trial in two arms. The probiotic group will consist of 42 patients. These patients will be recruited from the USP Bipolar Disorder Program. This program has an outpatient clinic that offers free medical care to a population of different ethnic groups, with the majority of subjects coming from the middle and lower social classes.

OTHER

Placebo Group

The 84 participants will participate in a randomized, double-blind, placebo-controlled trial in two arms. The placebo group will consist of 42 patients. These patients will be recruited from the USP Bipolar Disorder Program. This program has an outpatient clinic that offers free medical care to a population of different ethnic groups, with the majority of subjects coming from the middle and lower social classes.

Trial Locations (1)

05403010

RECRUITING

University of Sao Paulo, São Paulo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Baszucki Brain Research Fund

OTHER

collaborator

Milken Institute

OTHER

lead

University of Sao Paulo

OTHER

NCT05762887 - Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder | Biotech Hunter | Biotech Hunter